# Prevention and Treatment of Complications of Endovascular Methods in Patients With Malignant Liver Tumors

> **NCT04764409** · — · UNKNOWN · sponsor: **Central Clinical Hospital RZD-Medicine, Russian Federation** · enrollment: 500 (estimated)

## Conditions studied

- Hepatic Cancer
- Metastatic Cancer
- Chemotherapy Effect

## Interventions

- **PROCEDURE:** Chemoembolization
- **PROCEDURE:** Chemoinfusion

## Key facts

- **NCT ID:** NCT04764409
- **Lead sponsor:** Central Clinical Hospital RZD-Medicine, Russian Federation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-12
- **Primary completion:** 2022-12-12
- **Final completion:** 2023-12-12
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2021-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04764409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04764409, "Prevention and Treatment of Complications of Endovascular Methods in Patients With Malignant Liver Tumors". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04764409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*